Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Cagrilintide Long-Acting Amylin Analogue for Obesity Research Cagrilintide is a fatty acid-acylated long-acting amylin analogue developed by Novo Nordisk, designed for once-weekly dosing in obesity research protocols
The advantage is obvious, safe, controlled, and consistent results every time
We Accept HSA, FSA, Worker's Compensation, Care Credit, In-house financing
Peer review Peer review information Nature Metabolism thanks Timo Mller and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
US$ 22.37
US$ 25.25
US$ 20.64
US$ 29.89
